Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 299


Variance component analysis to assess protein quantification in biomarker validation: application to selected reaction monitoring-mass spectrometry.

Klich A, Mercier C, Gerfault L, Grangeat P, Beaulieu C, Degout-Charmette E, Fortin T, Mahé P, Giovannelli JF, Charrier JP, Giremus A, Maucort-Boulch D, Roy P.

BMC Bioinformatics. 2018 Mar 1;19(1):73. doi: 10.1186/s12859-018-2075-8.


Advancing the immunoaffinity platform AFFIRM to targeted measurements of proteins in serum in the pg/ml range.

Säll A, Corbee D, Vikström S, Ottosson F, Persson H, Waldemarson S.

PLoS One. 2018 Feb 13;13(2):e0189116. doi: 10.1371/journal.pone.0189116. eCollection 2018.


The cancer proteomic landscape and the HUPO Cancer Proteome Project.

Jimenez CR, Zhang H, Kinsinger CR, Nice EC.

Clin Proteomics. 2018 Jan 25;15:4. doi: 10.1186/s12014-018-9180-6. eCollection 2018.


Multiplexed targeted proteomic assay to assess coagulation factor concentrations and thrombosis-associated cancer.

Mohammed Y, van Vlijmen BJ, Yang J, Percy AJ, Palmblad M, Borchers CH, Rosendaal FR.

Blood Adv. 2017 Jun 20;1(15):1080-1087. doi: 10.1182/bloodadvances.2017007955. eCollection 2017 Jun 27.


Advances in Proteomic Techniques for Cytokine Analysis: Focus on Melanoma Research.

Kupcova Skalnikova H, Cizkova J, Cervenka J, Vodicka P.

Int J Mol Sci. 2017 Dec 13;18(12). pii: E2697. doi: 10.3390/ijms18122697. Review.


A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline.

Liu X, Zheng W, Wang W, Shen H, Liu L, Lou W, Wang X, Yang P.

Br J Cancer. 2017 Dec 5;117(12):1846-1854. doi: 10.1038/bjc.2017.365. Epub 2017 Nov 9. Erratum in: Br J Cancer. 2018 Feb 13;:.


Proteomic analysis of human lacrimal and tear fluid in dry eye disease.

Jung JH, Ji YW, Hwang HS, Oh JW, Kim HC, Lee HK, Kim KP.

Sci Rep. 2017 Oct 17;7(1):13363. doi: 10.1038/s41598-017-13817-y.


Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders.

Sjödin S, Hansson O, Öhrfelt A, Brinkmalm G, Zetterberg H, Brinkmalm A, Blennow K.

Proteomics Clin Appl. 2017 Dec;11(11-12). doi: 10.1002/prca.201700100. Epub 2017 Nov 2.


Revisiting biomarker discovery by plasma proteomics.

Geyer PE, Holdt LM, Teupser D, Mann M.

Mol Syst Biol. 2017 Sep 26;13(9):942. doi: 10.15252/msb.20156297. Review.


Absolute quantitation of disease protein biomarkers in a single LC-MS acquisition using apolipoprotein F as an example.

Kumar A, Gangadharan B, Cobbold J, Thursz M, Zitzmann N.

Sci Rep. 2017 Sep 21;7(1):12072. doi: 10.1038/s41598-017-12229-2.


Serum fibronectin distinguishes the early stages of hepatocellular carcinoma.

Kim H, Park J, Kim Y, Sohn A, Yeo I, Jong Yu S, Yoon JH, Park T, Kim Y.

Sci Rep. 2017 Aug 25;7(1):9449. doi: 10.1038/s41598-017-09691-3.


Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry.

Collins BC, Hunter CL, Liu Y, Schilling B, Rosenberger G, Bader SL, Chan DW, Gibson BW, Gingras AC, Held JM, Hirayama-Kurogi M, Hou G, Krisp C, Larsen B, Lin L, Liu S, Molloy MP, Moritz RL, Ohtsuki S, Schlapbach R, Selevsek N, Thomas SN, Tzeng SC, Zhang H, Aebersold R.

Nat Commun. 2017 Aug 21;8(1):291. doi: 10.1038/s41467-017-00249-5.


Development of a Multiplexed Assay for Oral Cancer Candidate Biomarkers Using Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry.

Hsiao YC, Chi LM, Chien KY, Chiang WF, Chen SF, Chuang YN, Lin SY, Wu CC, Chang YT, Chu LJ, Chen YT, Chia SL, Chien CY, Chang KP, Chang YS, Yu JS.

Mol Cell Proteomics. 2017 Oct;16(10):1829-1849. doi: 10.1074/mcp.RA117.000147. Epub 2017 Aug 18.


Multiplexed Liquid Chromatography-Multiple Reaction Monitoring Mass Spectrometry Quantification of Cancer Signaling Proteins.

Chen Y, Fisher KJ, Lloyd M, Wood ER, Coppola D, Siegel E, Shibata D, Chen YA, Koomen JM.

Methods Mol Biol. 2017;1647:19-45. doi: 10.1007/978-1-4939-7201-2_2.


A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression.

Llano DA, Bundela S, Mudar RA, Devanarayan V; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

PLoS One. 2017 Aug 3;12(8):e0182098. doi: 10.1371/journal.pone.0182098. eCollection 2017.


An Interlaboratory Evaluation of Drift Tube Ion Mobility-Mass Spectrometry Collision Cross Section Measurements.

Stow SM, Causon TJ, Zheng X, Kurulugama RT, Mairinger T, May JC, Rennie EE, Baker ES, Smith RD, McLean JA, Hann S, Fjeldsted JC.

Anal Chem. 2017 Sep 5;89(17):9048-9055. doi: 10.1021/acs.analchem.7b01729. Epub 2017 Aug 16.


Food allergen detection by mass spectrometry: the role of systems biology.

Croote D, Quake SR.

NPJ Syst Biol Appl. 2016 Sep 29;2:16022. doi: 10.1038/npjsba.2016.22. eCollection 2016. Review.


Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer.

Song E, Gao Y, Wu C, Shi T, Nie S, Fillmore TL, Schepmoes AA, Gritsenko MA, Qian WJ, Smith RD, Rodland KD, Liu T.

Sci Data. 2017 Jul 19;4:170091. doi: 10.1038/sdata.2017.91.


Tumor tissue protein signatures reflect histological grade of breast cancer.

Skoog P, Ohlsson M, Fernö M, Rydén L, Borrebaeck CAK, Wingren C.

PLoS One. 2017 Jun 26;12(6):e0179775. doi: 10.1371/journal.pone.0179775. eCollection 2017.


Effect of Sweetened Dried Cranberry Consumption on Urinary Proteome and Fecal Microbiome in Healthy Human Subjects.

Bekiares N, Krueger CG, Meudt JJ, Shanmuganayagam D, Reed JD.

OMICS. 2018 Feb;22(2):145-153. doi: 10.1089/omi.2016.0167. Epub 2017 Jun 15.

Supplemental Content

Support Center